CPHA Canvax

Respiratory syncytial virus (RSV) infection is a major cause of lower respiratory illness, particularly among infants, young children and older adults. In Canada, RSV causes yearly outbreaks of respiratory tract disease, usually starting in late fall and running through to early spring. Reinfections with RSV are common but illness is usually milder with subsequent infections.  At present there is no vaccine available in Canada to prevent RSV. The only means of prevention is temporary passive protection with the monoclonal antibody preparation palivizumab (PVZ). PVZ contains antibody only against RSV.

Rating See Comments Ratings


Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Monitoring and Surveillance,Outbreaks and Pandemics,Outbreaks Program Planning and Delivery
Program Delivery and Evaluation
Monitoring and Surveillance
Outbreaks and Pandemics


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.